Case Study Undergraduate 641 words Human Written

FDA Drug Review Process

Last reviewed: ~3 min read Therapy › Fda
80% visible
Read full paper →
Paper Overview

Clinical Protocol Differences The author of this response is asked to do a few things from a research standpoint. After which, the author shall answer a question related to the activities completed. First, the author of this response is to conduct a literature review about the protocols and methods used to develop a new drug and get it approved by the Food and...

Writing Guide
How to Write a Literature Review with Examples

Writing a literature review is a necessary and important step in academic research. You’ll likely write a lit review for your Master’s Thesis and most definitely for your Doctoral Dissertation. It’s something that lets you show your knowledge of the topic. It’s also a way...

Related Writing Guide

Read full writing guide

Related Writing Guides

Read Full Writing Guide

Full Paper Example 641 words · 80% shown · Sign up to read all

Clinical Protocol Differences The author of this response is asked to do a few things from a research standpoint. After which, the author shall answer a question related to the activities completed. First, the author of this response is to conduct a literature review about the protocols and methods used to develop a new drug and get it approved by the Food and Drug Administration and other relevant regulatory bodies.

Second, the author is asked to a similar review but one that pertains to studies and research that is simply meant to add to the knowledge base that exists in the medical and clinical sphere. The author must then consider the differences and similarities between the two and summarize that in the form of the author's discussion response. Summary Both knowledgebase studies and drug approval processes have one major similarity and that is to advance the field of medical science.

The field is all about saving lives, prolonging lives and helping everyone around the world in terms of medical care and quality of life. However, there is one stark difference between knowledgebase studies and those that pertain to drugs. When it comes to drugs and their approval, people will be taking those drugs. Drugs potentially come with nasty side effects and some people can even die when taking the wrong drug or the wrong combination of drugs. When it comes to knowledgebase articles, the stakes are rarely that high.

For example, if drug A is being considered for approval, there are extensive tests and trials. Those tests are done to ensure and verify whether the drug treats the diseases and/or disorders that it is meant to treat. At the same time, it has be verified whether there are any health risks involved. Anyone who has read the potential or likely side effect list for a drug knows those lists can be very extensive.

Even approved and commonly used drugs come with major warnings and/or restrictions and the perceived or actual effects of taking those drugs are often fodder for trial lawyers that only see dollar signs (Berenson, 2003). By contrast, knowledgebase articles are typically more benign. For sure, they could pertain to drugs and their effects but they are typically drugs that are already approved and commonly used. Other knowledgebase article relate to things that are somewhat removed from the medical care itself including the knowledge, perception and feelings of patients and practitioners.

Other times, the knowledgebase studies are assessing negative events like medical malpractice, adverse events and unexpected patient deaths. While those are surely tragic and the people directly involved are susceptible to investigation and regulation, the knowledgebase researchers that assess theses happenstances after the fact are in no such position. That being said, people engaging in knowledgebase articles and studies have strict standards they need to follow. Quite often, knowledgebase articles are shared with others via a peer-review process so as to verify the validity and reliability of the research findings.

It is not as if these knowledgebase people can just print anything they think is true. There has to.

129 words remaining — Conclusions

You're 80% through this paper

The remaining sections cover Conclusions. Subscribe for $1 to unlock the full paper, plus 130,000+ paper examples and the PaperDue AI writing assistant — all included.

$1 full access trial
130,000+ paper examples AI writing assistant included Citation generator Cancel anytime
Sources Used in This Paper
source cited in this paper
3 sources cited in this paper
Sign up to view the full reference list — includes live links and archived copies where available.
Cite This Paper
"FDA Drug Review Process" (2015, July 02) Retrieved April 22, 2026, from
https://www.paperdue.com/essay/fda-drug-review-process-2152393

Always verify citation format against your institution's current style guide.

80% of this paper shown 129 words remaining